61
Participants
Start Date
July 31, 2008
Primary Completion Date
November 30, 2008
pramipexole ER
placebo
248.637.01009 Boehringer Ingelheim Investigational Site, Birmingham
248.637.01033 Boehringer Ingelheim Investigational Site, Phoenix
248.637.01045 Boehringer Ingelheim Investigational Site, Tucson
248.637.01034 Boehringer Ingelheim Investigational Site, Hot Springs
248.637.01032 Boehringer Ingelheim Investigational Site, Arcadia
248.637.01044 Boehringer Ingelheim Investigational Site, Los Angeles
248.637.01036 Boehringer Ingelheim Investigational Site, Santa Ana
248.637.01042 Boehringer Ingelheim Investigational Site, Englewood
248.637.01031 Boehringer Ingelheim Investigational Site, Danbury
248.637.01035 Boehringer Ingelheim Investigational Site, DeLand
248.637.01023 Boehringer Ingelheim Investigational Site, Fort Myers
248.637.01047 Boehringer Ingelheim Investigational Site, Orlando
248.637.01043 Boehringer Ingelheim Investigational Site, Palm Beach Gardens
248.637.01040 Boehringer Ingelheim Investigational Site, Sunrise
248.637.01027 Boehringer Ingelheim Investigational Site, Tampa
248.637.01007 Boehringer Ingelheim Investigational Site, Atlanta
248.637.01028 Boehringer Ingelheim Investigational Site, Chicago
248.637.01010 Boehringer Ingelheim Investigational Site, Lexington
248.637.01016 Boehringer Ingelheim Investigational Site, Newton
248.637.01014 Boehringer Ingelheim Investigational Site, Lansing
248.637.01020 Boehringer Ingelheim Investigational Site, Flowood
248.637.01018 Boehringer Ingelheim Investigational Site, Picayune
248.637.01012 Boehringer Ingelheim Investigational Site, Kansas City
248.637.01017 Boehringer Ingelheim Investigational Site, Billings
248.637.01024 Boehringer Ingelheim Investigational Site, Albuquerque
248.637.01008 Boehringer Ingelheim Investigational Site, Albany
248.637.01002 Boehringer Ingelheim Investigational Site, New York
248.637.01025 Boehringer Ingelheim Investigational Site, Charlotte
248.637.01026 Boehringer Ingelheim Investigational Site, Fargo
248.637.01004 Boehringer Ingelheim Investigational Site, Cincinnati
248.637.01038 Boehringer Ingelheim Investigational Site, Columbus
248.637.01003 Boehringer Ingelheim Investigational Site, Oklahoma City
248.637.01046 Boehringer Ingelheim Investigational Site, Medford
248.637.01006 Boehringer Ingelheim Investigational Site, Portland
248.637.01039 Boehringer Ingelheim Investigational Site, Duncansville
248.637.01015 Boehringer Ingelheim Investigational Site, Warwick
248.637.01019 Boehringer Ingelheim Investigational Site, Austin
248.637.01037 Boehringer Ingelheim Investigational Site, San Antonio
248.637.01041 Boehringer Ingelheim Investigational Site, Salt Lake City
248.637.01021 Boehringer Ingelheim Investigational Site, Renton
248.637.01029 Boehringer Ingelheim Investigational Site, Seattle
248.637.01011 Boehringer Ingelheim Investigational Site, Spokane
Lead Sponsor
Boehringer Ingelheim
INDUSTRY